Theravance Biopharma, Inc.
USD17.06
-0.57 (-3.23%)
CEO
Rick E. Winningham
IPO Date
2014-05-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.97
Prev. Close
$17.63
Day Low
$16.97
Day High
$17.16
52W Low
$10.82
52W High
$21.03
Market Cap
$0.88B
Volume
3.10M
| 3,329 |
| $16.39 |
| 17 Jun 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S-Sale | Disposed | 3,328 | $16.38 |
| 17 Jun 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S-Sale | Disposed | 6,657 | $16.39 |
| 16 Jun 2026 | Smaldone Alsup Laurie | director | A-Award | Acquired | 6,009 | $0.00 |
| 16 Jun 2026 | Smaldone Alsup Laurie | director | A-Award | Acquired | 13,398 | $16.64 |
| 16 Jun 2026 | GRAY SUSANNAH | director | A-Award | Acquired | 6,009 | $0.00 |
| 16 Jun 2026 | GRAY SUSANNAH | director | A-Award | Acquired | 13,398 | $16.64 |
| 16 Jun 2026 | MITCHELL DEAN J | director | A-Award | Acquired | 6,009 | $0.00 |
| 16 Jun 2026 | MITCHELL DEAN J | director | A-Award | Acquired | 13,398 | $16.64 |